Rising Liver Cancer Mortality in Europe Linked to Hepatitis B and C Infections Amidst Variance in Prevention and Treatment Primary liver cancer is the sixth most common cause of cancer-related deaths in Europe. Infection with hepatitis B or C is one of the main risk […]

DiCE’s Report from the AMMF Annual Cholangiocarcinoma Conference The Alan Moremont Memorial Fund (AMMF) is the UK’s Cholangiocarcinoma charity. Its annual conference brings together UK and international experts w […]

DiCE Elevates Patient Advocacy Skills at WECAN Academy in Barcelona Digestive Cancers Europe (DiCE) had the incredible opportunity to attend the WECAN Academy in the sunny city of Barcelona. Our goal at DiCE is to […]

PerMICCion: A Study on Transforming Colorectal Cancer Prevention and Treatment through Gut Microbiome Research More than 5 million people worldwide are living with colorectal cancer (CRC), making it the third most common cancer globally. Alarmingly, this […]

Appeal to President von der Leyen to Appoint a Vice-President for Health, Wellbeing, and Social Rights DiCE and 30 organisations brought together by the EU4Health Civil Society Alliance have published a letter to European Commission President-Elect […]

Von der Leyen's Reelection Could Mean Continuity, Yet Shifts in Health Priorities May Impact Cancer Funding We have come to the end of one political cycle and Ursula von der Leyen has been re-elected as the President of the European Commission. At the time […]

Closing the Gap between Hype and Hope: New Report Examines How Health Systems Can Prepare for the Future of Cancer Diagnosis The Health Policy Partnership (HPP) has worked with an expert steering committee to publish a report outlining the policy actions needed to prepare […]

Do You Want to Have a Say in which Treatments Will Be Available in EU Countries? Get involved in EU HTA What is the EU HTA Regulation? Health Technology Assessment (HTA) is the process of assessing the added value of new health technologies (e.g. […]

Early-Age Onset Digestive Cancers – a Global Review of this Worrisome Trend The term ‘early-onset digestive cancers’ refers to digestive cancers arising in people under the age of 50. When it comes to digestive cancers, what […]

Will the New European Parliament be a Healthy One? So, the dust has settled after the European elections, and now, frantic bargaining begins on who will have what position and which Committees will […]

Uniting for Liver Health: DiCE Advances Dialogue at the 59th EASL Congress in Milan Digestive Cancers Europe was an active participant in the 59th edition of the European Association for the Study of the Liver Congress in Milan from […]

Empowering Patients Together: DiCE and EUPATI Join Forces We are happy to share that Digestive Cancers Europe (DiCE) and the European Patients’ Academy on Therapeutic Innovation (EUPATI) have teamed up to i […]

Reflecting on a Milestone: The Successful Romanian Policy Event on Digestive Cancers June 2, 2024 – The recent Romanian policy event on digestive cancers, held on May 28, has left us with a sense of profound accomplishment and […]

Launching the Gastric Cancer Project Promotion: A Step Forward in Patient Care April 24, 2024 — The Recover with Us Association is thrilled to announce the launch of the Gastric Cancer Project Promotion, made possible by the g […]

Putting a Spotlight on Digestive Cancers in the Polish Parliament On May 21, DiCE, together with our Polish member organisation EuropaColon Poland Foundation, had the pleasure of voicing the concerns of digestive […]

GUIDE.MRD Consortium Holds Productive 2nd Annual General Assembly in Hamburg The GUIDE.MRD consortium partners met for the 2nd annual general assembly, which was hosted by the coordinating institution (University Hamburg […]

EMA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer Irinotecan hydrochloride trihydrate (Onivyde pegylated liposomal) was approved in March 2024 by the European Medicines Agency […]

Advancing Right to be Forgotten It is usually a safe bet to say something important should be announced when you see two Commissioners on an event agenda. However, that was not the […]

Fruquintinib: A New Medicine for mCRC Recommended for Approval in Europe A new medicine for metastatic colorectal cancer (mCRC) has been recommended for approval by the European Medicines Agency (EMA). Called […]

Extending Colonoscopy Screening Intervals: A New Approach to Colorectal Cancer Prevention Having a colonoscopy is the best way to check and screen for colorectal cancer (CRC). A small camera on a bendy tube is passed through the anus and […]